Search results
Results from the WOW.Com Content Network
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...
It was developed by Sanofi. The most common side effect is hypoglycemia (low blood glucose levels). [61] Insulin glulisine was approved for medical use in the United States [59] [62] and the European Union in 2004. [61] It is currently patented by Sanofi, and is therefore only produced by said company under the brand name Apidra. [63]
2008: Sanofi Pasteur acquires Acambis plc, a biotech company. 2009: Sanofi Pasteur acquires major stake in Hyderabad-based Shantha Biotechnics. [21] 2020: Sanofi Pasteur and GlaxoSmithKline have said they are starting clinical trials of their coronavirus vaccine. They hope to have the first results of the trial by December and if it is ...
Sanofi said the spinoff would allow it to increase its focus on innovative medicines and vaccines. Sanofi’s consumer health unit boasts a portfolio that includes popular over-the-counter ...
In June 2016, the company announced it had struck an asset-swap deal with Sanofi, Boehringer would sell its consumer health division (valuing it at €6.7 billion) and €4.7 billion in cash, whilst acquiring the Merial animal health division (valuing it at €11.4 billion / $12.4 billion).
However, the WHO does not recommend the use of A. annua plant materials, including tea, for the prevention and treatment of malaria. [70] In 2013, Sanofi announced the launch [61] of a production facility in Garessio, Italy, to manufacture the
NEW YORK (Reuters) -Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did ...
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland.